GGRUX
Price
$13.65
Change
-$0.18 (-1.30%)
Updated
Jun 13 closing price
Net Assets
192.5M
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

GGRUX vs RGEBX

Header iconGGRUX vs RGEBX Comparison
Open Charts GGRUX vs RGEBXBanner chart's image
Goldman Sachs Strategic Growth R6
Price$13.65
Change-$0.18 (-1.30%)
VolumeN/A
Net Assets192.5M
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
GGRUX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GGRUX vs. RGEBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGRUX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. GGRUX (192M). GGRUX (0.00) and RGEBX (0.00) have matching dividends . GGRUX was incepted earlier than RGEBX: GGRUX (10 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than GGRUX (0.95). GGRUX is a more actively managed with annual turnover of: 39.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than GGRUX: RGEBX (250) vs GGRUX (5000000). GGRUX annual gain was more profitable for investors over the last year : 11.52 vs. RGEBX (7.68). RGEBX return over 5 years is better than : 45.42 vs. GGRUX (31.52).
GGRUXRGEBXGGRUX / RGEBX
Total Expense Ratio0.741.0968%
Annual Report Gross Expense Ratio0.951.0987%
Fund Existence10 years11 years-
Gain YTD1.2614.82926%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets192M306B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.527.68150%
Returns for 3 years56.0051.01110%
Returns for 5 years31.5245.4269%
Returns for 10 yearsN/A65.87-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd